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Pancreatic and duodenal homeobox 1 (Pdx1) is a transcription factor that regulates the embryonic develop-
ment of the pancreas and the differentiation toward b cells. Previously, we have shown that exposure of mouse 
embryonic stem cells (mESCs) to high concentrations of diethylenetriamine nitric oxide adduct (DETA-NO) 
triggers differentiation events and promotes the expression of Pdx1. Here we report evidence that Pdx1 expres-
sion is associated with release of polycomb repressive complex 2 (PRC2) and P300 from its promoter region. 
These events are accompanied by epigenetic changes in bivalent markers of histones trimethylated histone H3 
lysine 27 (H3K27me3) and H3K4me3, site-specific changes in DNA methylation, and no change in H3 acetyla-
tion. On the basis of these findings, we developed a protocol to differentiate mESCs toward insulin-producing 
cells consisting of sequential exposure to DETA-NO, valproic acid, and P300 inhibitor (C646) to enhance Pdx1 
expression and a final maturation step of culture in suspension to form cell aggregates. This small molecule-
based protocol succeeds in obtaining cells that express pancreatic b-cell markers such as PDX1, INS1, GCK, 
and GLUT2 and respond in vitro to high glucose and KCl.
Key words: Embryonic stem cells (ESCs); Nitric oxide (NO); Cell differentiation;  
Insulin-producing cells; Diabetes
INTRODUCTION
Research efforts have been made over the last 15 years 
to generate pancreatic b-cell surrogates from stem cells. 
Thus, generation of definitive endoderm from embryonic 
stem cells (ESCs) and subsequent differentiation into 
pancre atic progenitors and glucose-responsive pancreatic 
b cells have been reported1–8. The biology of pancreas 
development might be instrumental in providing infor-
mation to optimize current differentiation protocols. In 
this regard, the transcription factor pancreatic and duode-
nal homeobox 1 (Pdx1) stands out as a relevant regula-
tor of pancreatic development and differentiation toward 
b cells9,10. Pdx1 gene expression is controlled by the 
interaction of a set of transcription factors with highly 
conserved sequences of its promoter11. Additional regula-
tory mechanisms such as DNA methylation and histone 
covalent modifications have been reported to be relevant 
in the repression of Pdx1 in a model of type 2 diabetes12.
On the other hand, polycomb repressive complex 2 
(PRC2) plays a role in the regulation of key developmen-
tal genes in ESCs13,14. PRC2 catalyzes di- and trimethyla-
tion of histone H3 Lys 27 residue (H3K27me2/3), which 
has been associated with the silencing of target genes13–16. 
PRC2 recruitment to target genes is dependent on jumonji, 
AT rich interactive domain 2 (JARID-2), whose expression 
is regulated by stemness factors octamer-binding transcrip-
tion factor 4 (OCT-4), (sex-determining region Y)-box 2 
(SOX2), and NANOG17–22. Indeed, PRC2 activity represses 
Pdx1 gene expression17, and epigenetic changes of the Pdx1 
gene have been reported in ESCs during generation of pan-
creatic endoderm (PE)23. On the other hand, persistence of 
both acetyl-histone H3 (AcH3) and trimethylated histone 
Delivered by Ingenta to: Guest User
IP: 193.147.188.5 On: Tue, 31 Jan 2017 08:18:11
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
1880 SALGUERO-ARANDA ET AL.
H3 lysine 27 (H3K27me3) marks on the silent Pdx1 gene 
in hepatoblasts has been reported24. In addition, histone 
acetyltransferase P300 activity has been reported to be 
involved in the selection of liver over pancreas fate24. P300 
also acts as a repressor independently of its acetyltrans-
ferase activity, since sumoylation of cell cycle regulatory 
domain 1 (CRD1), a repressor domain of P300, induces 
the recruitment of histone deacetylase 6 (HDAC6) to pro-
moters susceptible to P300-mediated repression such as 
p21 and survivin25,26.
Nitric oxide (NO) is a regulator of stem cell fate, and 
successful generation of definitive endoderm from ESCs 
has been achieved by exposure to chemical NO donors 
in a differentiation protocol with transient expression 
of Pdx1 during the process6,27. In the present study, we 
sought to explore the mechanisms involved in the regu-
lation of Pdx1 by NO and found that this action entails 
the release of PRC2 and P300 from its promoter region. 
These events are accompanied by changes in bivalent 
marks of histone H3K27me3 and H3K4me3 and in the 
methylation status of specific CpG islands. Given the 
role of P300 in the regulation of Pdx1, we optimized a 
differentiation protocol for generating insulin-producing 
cells from ESCs by the addition of P300 inhibitor C646 
(P300i) followed by culture in suspension. This protocol 
succeeds in obtaining cell clusters with sustained expres-
sion of pancreatic b-cell markers such as Pdx1, insulin-1 
(Ins1), glucokinase (Gck), Kir6.2, and glucose transporter, 
member 2 (Glut2) and that are responsive to conventional 
secretagogues such as glucose and KCl.
MATERIALS AND METHODS
Cell Culture and Treatments
Mouse ESC (mESC) lines D3 and R1/E [American Type 
Culture Collection (ATCC), Manassas, VA, USA] were used. 
INS-1E cells were provided by Dr. P. Maechler (Geneva 
University, Geneva, Switzerland). D3 and R1/E mESCs 
were maintained in feeder free culture at 37°C with 5% CO2 
in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, 
Grand Island, NY, USA), supplemented with 15% fetal 
bovine serum (FBS) (Hyclone, Logan, UT, USA), 0.1 mM 
b-mercaptoethanol (Gibco, Paisley, Scotland, UK), 2 mM 
l-glutamine (Gibco, Paisley, Scotland, UK), 1% minimum 
essential medium (MEM) nonessential amino acids (Gibco, 
Paisley, Scotland, UK), and 100 U/ml penicillin:100 μg/ml 
streptomycin (Gibco, Paisley, Scotland, UK). The undif-
ferentiated state was maintained by addition of leukemia 
inhibitory factor (LIF) (1,000 U/ml) (ESGRO, Chemicon, 
Charlottesville, VA, USA). INS-1E cells were cultured in 
Roswell Park Memorial Institute (RPMI)-1640 medium 
(Lonza, Verviers, Belgium), supplemented with 10% FBS, 
10 mM N-2-hydroxyethylpiperazine-N-2-ethane sulfo-
nic acid (HEPES; Gibco, Paisley, Scotland, UK), 1 mM 
sodium pyruvate (Gibco, Paisley, Scotland, UK), 100 U/
ml penicillin:100 μg/ml streptomycin, 2 mM l-glutamine, 
and 50 μM b-mercaptoethanol (Gibco, Paisley, Scotland, 
UK). R1/E cells, which were used to study the Pdx1 gene 
regulation, were cultured for 3 days in gelatinized dishes in 
the presence or absence of LIF and then exposed to 500 μM 
diethylenetriamine nitric oxide adduct (DETA-NO) (Sigma-
Aldrich, St. Louis, MO, USA) for 19 h. Cultured cells were 
then disaggregated with trypsin solution (Gibco, Paisley, 
Scotland, UK) and collected by centrifugation at 230 × g. 
For differentiation protocols, D3 cells were cultured for 
3 days without LIF, 19 h with 500 μM DETA-NO, 6 days 
with 100 μM valproic acid (Sigma-Aldrich), and 20 h with 
50 μM P300 inhibitor C646 (Millipore, Darmstadt, Ger-
many). Cell aggregates were then gently scraped and trans-
ferred to Falcon tubes (Thermo Fisher Scientific, Waltham, 
MA, USA) and allowed to sediment for 10 min. The result-
ing aggregates were then grown in suspension in 12- to 
24-well plates for 3 days. On the fifth day of culture, FBS 
was reduced to 2% until the end of the protocol. Culture 
medium was changed daily.
RNA Isolation, Reverse Transcription PCR,  
and Real-Time PCR Analysis
Total RNA was extracted using Easy Blue reagent (Intron 
Biotechnology, Gyeonggi-do, South Korea) and chloro-
form/isopropanol purification procedure. cDNA synthe-
sis was performed with 1 μg of total RNA using Moloney 
murine leukemia virus (M-MVL) reverse transcriptase 
(Promega, Madison, WI, USA) and random primers 
according to the manufacturer’s instructions. Genes were 
analyzed by qualitative polymerase chain reaction (PCR). 
Primer melting temperature (Tm) for all genes was 
designed at 60°C using MyTaq Red DNA polymerase 
(Bioline Reagents Ltd, London, UK) with the following 
specifications: amplification for 35–40 cycles of denatur-
ation at 95°C for 30 s, annealing at 60°C for 15 s and 
extension at 72°C for 30 s, and a final extension at 72°C 
for 10 min. PCR was performed in a MyCycler (Bio-Rad 
Laboratories, Hercules, CA, USA) thermal cycler. For 
real-time PCR (RT-PCR) analysis, endogenous mRNA 
levels were measured based on SYBR Green (Applied 
Biosystems, Foster City, CA, USA) detection with the 
ABI Prism 7500 machine (Applied Biosystems). Results 
were normalized with b-actin expression. PCR primers 




Cells were trypsinized, centrifuged at 230 × g, and 
washed once with cold phosphate-buffered saline (PBS) 
(Gibco, Paisley, Scotland, UK). Cell pellets were then 
resuspended and incubated in radioimmunoprecipitation 
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assay (RIPA) buffer (Sigma-Aldrich) supplemented with 
protease inhibitors (Sigma-Aldrich) and phosphatase inhi-
bitor cocktail (Sigma-Aldrich) for 45 min on ice and 
sonicated with four pulses (10 s each) at 10% amplitude 
in a Branson sonifier (Branson Ultrasonics Corporation, 
Danbury, CT, USA). After centrifugation at 9,300 × g, pro-
tein content in supernatants were quantified by Bradford 
assay. Proteins were denatured in Laemmli buffer con-
taining 62.5 mM Tris-HCl (pH 6.8), 2% sodium dodecyl 
sulfate (SDS), 10% glycerol, 0.01% bromophenol blue, 
and 2.5 % b-mercaptoethanol (all Sigma-Aldrich) for 
10 min at 96°C. Proteins were separated by SDS polyacryl-
amide gel electrophoresis (SDS-PAGE) and transferred 
to polyvinylidene difluoride (PVDF) membranes (GE 
Healthcare, Buckinghamshire, UK). Membranes were 
then blocked with Tris-buffered saline (Sigma-Aldrich) 
supplemented with 0.1% Tween 20 (TBST; Sigma-Aldrich) 
containing 5% skim milk (Becton Dickinson, Franklin 
Lakes, NJ, USA) for 1 h at room temperature (RT). 
Then membranes were probed with anti-Pdx1 (1:2,000; 
Abcam, Cambridge, UK), anti-P300 (1:1,000; Santa 
Cruz Biotechnology, Heidelberg, Germany), anti-Jarid-2 
(1:1,000; Abcam), anti-Ezh2 (1:500; BD Biosciences, 
San Jose, CA, USA), and anti-b-actin (1:10,000; Sigma-
Aldrich) in TBST with 5% skim milk overnight at 4°C. 
Membranes were subsequently washed three times 
with TBST. Secondary antibodies used were anti-rabbit 
immunoglobulin G (IgG) (1:20,000, Sigma-Aldrich) and 
anti-mouse IgG (1:40,000; Jackson ImmunoResearch, 
Suffolk, UK). Proteins were detected by chemilumines-
cence with WesternBright ECL HRP substrate (Advansta 
Inc., Menlo Park, CA, USA).
Immunocytochemistry
R1/E cells (1.5 × 104) were cultured in wells containing 
Permanox slides (Thermo Fisher Scientific) and main-
tained at 37°C with 5% CO2. To analyze PDX1 expression, 
cells exposed to DETA-NO for 19 h were fixed with 4% 
paraformaldehyde (PFA) (Panreac AppliChem, Barcelona, 
Spain), permeabilized with cold methanol, and blocked 
with 4% bovine serum albumin (BSA) (Sigma-Aldrich). 
Cells were incubated overnight with anti-Pdx1 (1:100; 
Abcam) and anti-a-tubulin (1:300; Sigma-Aldrich). For 
immunofluorescence of islet-like clusters (D3 cells), clus-
ters were fixed with 4% PFA in PBS overnight at 4°C, 
dehydrated with ethanol and xylene, and embedded in par-
affin (Merk, Darmstadt, Germany). Sections were cut at 
a thickness of 5 μm with a Leica DM6000B microtome 
(Leica Microsystems Inc., Concord, ON, Canada). Sections 
were deparaffinized through a series of xylene and etha-
nol washes, incubated in PBS for 5 min, and the samples 
were autoclaved with a 0.01 M citrate buffer (Sigma-
Aldrich) for antigen retrieval. Sections were blocked with 
3% BSA and 0.2% Triton X-100 (Sigma-Aldrich) in PBS 
for 1 h at RT and incubated overnight at 4°C with anti-
Pdx1 (1:100; Developmental Studies Hybridoma Bank, 
Iowa City, IA, USA), anti-C-peptide (1:100; Beta Cell 
Biology, Vanderbilt University, Nashville, TN, USA), and 
anti-Glut2 (1:100; Chemicon). Finally, cells were washed 
three times with PBS and 0.1% Tween (PBST), and detec-
tion of primary antibodies was carried out using anti-rabbit 
Alexa Fluor 594 (1:300; Invitrogen, Carlsbad, CA, USA) 
and anti-mouse Alexa Fluor 488 (1:300, Invitrogen). 
4¢,6-Diamidino-2-phenylindole (DAPI) (Sigma-Aldrich) 
counterstaining was also performed. Fluorescent images 
were visualized with a Leica DM 5500 microscope (Leica 
Microsystems, Wetzlar, Germany). Images were processed 
with Adobe Photoshop (Adobe Systems Incorporated, 
San Jose, CA, USA).
Flow Cytometry
Cultured cells were detached by trypsinization and col-
lected following centrifugation at 230 × g. Cell pellets were 
fixed with 4% PFA for 10 min at RT, permeabilized with 
0.5% Triton X-100 for 10 min on ice, and blocked with 
PBS 5% FBS at 4°C for 30 min. Cells were then incubated 
at 4°C for 1 h with anti-Pdx1 (1:600; Abcam) or anti-rab-
bit IgG-phycoerythrin (PE) goat isotype control (1:600; 
Abcam) in PBS 5% FBS. Cells were washed three times at 
4°C with PBS and exposed to the secondary antibody, anti-
rabbit IgG-PE (1:500; Abcam), for 30 min at RT. After three 
washes with PBS, cells were resuspended in 500 μl of PBS, 
and fluorescence readouts were carried out by flow cytom-
etry (BD FACSCalibur; BD Biosciences).
Bisulfite Sequencing PCR (BSP)
A region of approximately 2,000 base pairs (bp) 
of the Pdx1 promoter was analyzed with the software 
Methyl Primer Express v1.0. (Applied Biosystems) to 
identify CpG-rich islands. Primers designed for these 
regions are listed in Supplementary Table 1 (available at 
http://www.cabimer.es/web/docs/grupos/tcmr2/Material 
SuplementarioCellTrasplantation.zip). Then genomic DNA 
from 7.5 × 104 cells was converted with sodium bisulphite 
using the Cells-to-CpG Bisulphite Conversion Kit (Applied 
Biosystems). Converted DNA was amplified by PCR using 
MyTaq HS Red DNA Polymerase (Bioline Reagents), and 
then PCR products were purified and cloned into pGEM-T 
to obtain Escherichia coli (E. coli) colonies. Ten colonies 
per treatment were analyzed by PCR and later sequenced 
in a DNA analyzer 3730 (Applied Biosystems). The results 
were analyzed by the BiQ Analyzer Software (Max-Planck-
Institute and Saarland University, Saarbrücken, Germany).
Bisulfite Pyrosequencing
The results obtained by BSP were confirmed by pyro-
sequencing. Sodium bisulphite modification of genomic 
DNA of 7.5 × 104 cells was carried out as described above. 
Delivered by Ingenta to: Guest User
IP: 193.147.188.5 On: Tue, 31 Jan 2017 08:18:11
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
1882 SALGUERO-ARANDA ET AL.
Converted DNA was eluted in 15 μl, and 2 μl was used for 
each PCR cycle. Primers used for PCR and sequencing 
were designed using PyroMark assay design software, ver-
sion 2.0.01.15 (Qiagen, Hilden, Germany). Pyrosequenc ing 
primers are shown in Supplementary Table 1 (available at 
http://www.cabimer.es/web/docs/grupos/tcmr2/Material 
SuplementarioCellTrasplantation.zip). These primers were 
designed to hybridize with CpG-free sites to ensure meth-
ylation-independent amplification. PCR was performed 
with biotinylated primers to convert the PCR product to 
single-stranded DNA templates using the Vacuum Prep Tool 
(Biotage, Uppsala, Sweden) according to the manufactur-
er’s instructions. Pyrosequencing reactions and methylation 
quantification were performed in a PyroMark Q24 System 
version 2.0.6 (Qiagen).
Chromatin Immunoprecipitation Assay (ChIP)
Cells were cross-linked with 1% (w/v) formaldehyde 
(Sigma-Aldrich) for 10 min at 37°C. Cells (3 × 106) were 
resuspended in lysis buffer containing 10 mM NaCl, 10 mM 
Tris-HCl (pH 8), 3 mM Cl2Mg, and 0.5 mM DTT supple-
mented with protease inhibitors (Sigma-Aldrich) for 10 min 
on ice. Cells were then centrifuged for 5 min at 800 × g at 
4°C. Supernatants were discarded, and the nuclei-containing 
fraction was washed by gentle inversion with buffer contain-
ing 10 mM Tris-HCl (pH 8), 15 mM NaCl, and 60 mM KCl 
(Sigma-Aldrich). Cell nuclei were subsequently centrifuged 
for 5 min at 800 × g at 4°C and incubated with washing buf-
fer supplemented with 3 mM CaCl2, protease inhibitors, 
0.5 mM 1,4-dithiothreitol (DTT; Sigma-Aldrich), and 
5–10 μl of micrococcal nuclease (1:200 dilution) (New 
England BioLabs, Ipswich, MA, USA). Cell nuclei were 
incubated for 20 min at 37°C with orbital shaking. Nuclease 
activity was halted by the addition of 20 μl of 0.5 mM ethyl-
enediaminetetraacetic acid (EDTA; Sigma-Aldrich). Cell 
nuclei were centrifuged for 5 min at 800 × g at 4°C and 
lysed with buffer containing 150 mM NaCl, 50 mM Tris-
HCl (pH 7.5), 5 mM EDTA, 0.5% NP-40, 1% Triton, and 
0.01% SDS and sonicated with three pulses for 10 s each 
at 10% amplitude in a Branson sonifier. Extracts were then 
centrifuged for 10 min at 9,300 × g at 4°C. Supernatants 
containing chromatin with an average size of 500 bp were 
immunoprecipitated with anti-P300 (4 mg; Santa Cruz 
Biotechnology), anti-Jarid-2 (3 mg; Abcam), anti-acetylated 
H3 (1 mg; Abcam), anti-H3K4me3 (1 mg; Abcam), and anti-
H3K27me3 (1 μg; Cell Signaling Technology Inc.; Danvers, 
MA, USA). Rabbit control IgG (Abcam) and mouse IgG1 
isotype control mAb (Cell Signaling Technology Inc.) were 
used as ChIP controls. Dynabeads (15 μl; Invitrogen Dynal 
AS, Oslo, Norway) was used to prepare Ab–bead com-
plexes and incubated for 30 min at 4°C under rotation in 
dilution buffer [0.01% SDS, 1.1% Triton X-100, 1.2 mM 
EDTA, 16.7 mM Tris-HCl (pH 8.1), 167 mM NaCl]. Then 
chromatin was added and incubated for 1 h. Washes of the 
complex were once with low-salt buffer [0.1% SDS, 1% 
Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.1), 
150 mM NaCl], once with high-salt buffer [0.1% SDS, 
1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl (pH 
8.1), 500 mM NaCl], once with LiCl buffer [0.25 M LiCl 
(Sigma-Aldrich), 1% Igepal CA-630 (Sigma-Aldrich), 
1% deoxycholate (Sigma-Aldrich), 1 mM EDTA, 10 mM 
Tris-HCl (pH 8)], twice with TE buffer [10 mM Tris-HCl 
(pH 8.1), 1 mM EDTA], and finally eluted with 500 μl 
of 1% SDS, 0.1 M NaHCO3 (Sigma-Aldrich) solution. 
DNA was purified by phenol/chloroform procedure. In 
brief, 500 ml of phenol/chloroform (Panreac AppliChem) 
was added to the solution containing DNA and stirred 
vigorously. After centrifugation at 9,300 × g for 10 min, 
the upper aqueous phase was transferred to a new tube 
and washed twice with ethanol. Finally, DNA was eluted 
in 20 ml of water. ChIP analysis was performed by real 
time-PCR using SYBR Green (Bio-Rad). Promoter occu-
pancy was determined by the percent input method nor-
malized to the condition favoring pluripotency. Primers 




Cells were trypsinized from culture dishes, centri-
fuged, and washed once with cold PBS. Cell pellets were 
then resuspended and incubated in nondenaturing lysis 
buffer containing 50 mM Tris-HCl (pH 7.4), 300 mM 
NaCl, 5 mM EDTA, 0.1 mM neocuproine (Sigma-
Aldrich), and 1% Triton X-100, supplemented with pro-
tease inhibitor cocktail (Sigma-Aldrich) for 45 min on ice 
and subsequently sonicated with four pulses for 10 s each 
at 10% amplitude. Following centrifugation, supernatant 
proteins were quantified by Bradford assay. Samples con-
taining 3 mg of protein were incubated with 3 μg of anti-
Jarid-2 (Abcam) for 2 h with stirring at 4°C. Then 70 μl 
of Dynabeads protein A (Thermo Fisher Scientific) was 
attached to the complex antibody–proteins overnight at 
4°C. The samples were washed three times with nonde-
naturing lysis buffer for 5 min with stirring at 4°C and 
washed one last time with 200 μl of 50 mM Tris (pH 8). 
Proteins were denatured with 50 μl of 1× Laemmli buffer 
supplemented with 2.5% b-mercaptoethanol, separated 
by gradient SDS-PAGE (Mini-Protean TGX Gels; 4–15% 
acrylamide; Bio-Rad), and transferred to PVDF mem-
branes. Finally, membranes were blocked with TBST 
and 5% nonfat dried milk for 30 min at RT and probed 
with anti-Jarid-2 (1:1,000; Abcam), anti-P300 (1:1,000; 
Santa Cruz Biotechnology), and anti-Ezh2 (1:500; BD 
Biosciences). Secondary antibodies were anti-rabbit IgG 
(1:20,000; Sigma-Aldrich) and anti-mouse IgG (1:40,000; 
Jackson ImmunoResearch). Total protein (100 μg) was 
loaded as a control.
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Glucose-Stimulated Insulin Secretion
Clusters were washed two times for 30 min at 37°C 
with homemade Krebs buffer (135 mM NaCl, 3.6 mM 
KCl, 5 mM NaHCO3, 10.5 mM MgCl2, 0.5 mM NaH2PO4, 
2.5 mM CaCl2, 10 mM HEPES, and 0.1% BSA; all Sigma-
Aldrich) and were exposed to Krebs buffer containing 
3 mM glucose for 1 h, and supernatant was collected. 
Clusters were then incubated in Krebs buffer contain-
ing either 20 mM glucose or 25 mM KCl for 1 h, and 
supernatant was collected. Insulin release was measured 
with the Ultrasensitive Mouse Insulin Enzyme-linked 
Immunosorbent Assay (ELISA) kit (Mercodia, Uppsala, 
Sweden). DNA of cell clusters was extracted and quan-
tified (Nanodrop ND1000 spectrophotometer; Thermo 
Fisher Scientific).
Statistical Analyses
Data are means ± standard error of mean (SEM), and 
comparisons between values were analyzed using one-
tailed Student’s t-test with SigmaPlot software (Systat 
Software Inc., San Jose, CA, USA). Values of p < 0.05 
were considered statistically significant.
RESULTS
NO Induces Pdx1 Expression
R1/E mESCs cultured for 3 days in the presence or 
absence of LIF and 500 mM DETA-NO (19 h) increase Pdx1 
expression, both at the mRNA and protein levels (Fig. 1A 
and B). Dose response experiments show that PDX1 pro-
tein levels were significantly increased upon exposure of 
R1/E and D3 mESCs to 500 μM DETA-NO (supplemen-
tary Fig. 1, available at http://www.cabimer.es/web/docs/
grupos/tcmr2/MaterialSuplementarioCellTrasplantation.
zip). Moreover, immunofluorescence studies reveal that 
PDX1 is localized in the nuclei (Fig. 1C). The population 
of cells treated with DETA-NO displays a rightward shift 
in cytometry plots, thus suggesting an enhanced expres-
sion of PDX1 protein (Fig. 1D). Quantification of fluo-
rescence intensity shows that PDX1-positive cells have 
significantly increased fluorescence following exposure 
to DETA-NO (Fig. 1E).
Impact of NO on the Epigenetic Changes 
of Pdx1 Promoter
To gain insight into the molecular processes involved 
in the effect of NO on Pdx1 expression, analysis of epige-
netic changes occurring at the Pdx1 promoter region was 
undertaken. Three CpG islands were detected by Methyl 
Primer Express software (Thermo Fisher Scientific): 
(−2,000, −1,600), (−350, 650), (1,150, 1,650) bp from the 
translation start. We focused our study on islands dubbed 
distal CpG (−2,000, −1,600) and proximal CpG (−350, 
650) since it has been reported that the three conserved 
and functionally important subdomains (areas I, II, and 
III) are localized between −2,800 and −1,60011, and it 
has been found that methylation of the Pdx1 proximal 
promoter (from −275 to +1 bp) is associated with Pdx1 
silencing12,28 (Fig. 2A). Bisulfite sequencing PCR analy-
sis shows methylation of 47 CpG sites, belonging to both 
proximal and distal CpG islands. DETA-NO treatment 
leads to enhanced methylation of CpG sites 8, 22, and 
46, and demethylation of CpG site 40 in the presence 
or absence of LIF (Fig. 2B). The pyrosequencing study 
shows similar results, with the methylation level of the 
distal CpG island being higher than the methylation level 
of the proximal CpG island. The degree of distal CpG 
island methylation of cells cultured in the presence of LIF 
is lower than cells cultured in the absence of LIF. Exposure 
to DETA-NO leads to increased methylation that is simi-
lar to the methylation level of INS-1E cells. Regarding 
the methylation level of the proximal CpG island, cells 
cultured in the absence of LIF and with DETA-NO pres-
ent a methylation pattern similar to that of INS-1E cells. 
This rat cell line was used as a positive control of Pdx1 
expression29 because they constitute a stable and glucose-
responsive b-cell surrogate30. Twelve to 16 CpG sites 
were not analyzed in INS-1E cells because that region is 
not conserved between mice and rats (Fig. 2C).
On the other hand, histone marks in the proximal region 
of the Pdx1 promoter were studied by ChIP. Occupancy 
of acetylated H3 at the Pdx1 promoter was studied, and 
the results show that exposure to DETA-NO does not sig-
nificantly affect acetylated H3 occupancy (Fig. 2D). By 
contrast, the occupancy ratio H3K27me3/H3K4me3 was 
affected by DETA-NO treatment, both in the presence or 
absence of LIF.
Role of PRC2 in the Regulation of Pdx1 Expression
To further investigate the mechanism underlying NO- 
induced decreases in H3K27me3 occupancy on the Pdx1 
promoter, the expression and function of PRC2 proteins 
JARID-2 and EZH2 were studied. Results show that while 
EZH2 does not change its expression following NO treat-
ment, JARID-2 expression is decreased, both at the mRNA 
and protein levels (Fig. 3A and B). To ascertain if PRC2 
directly represses Pdx1 expression, JARID-2 occupancy at 
the Pdx1 proximal promoter was studied by ChIP. The result 
indicates that JARID-2 is released significantly from the 
Pdx1 promoter after DETA-NO treatment (Fig. 3C).
Furthermore, we studied the contribution of histone 
acetyltransferase P300 to the regulation of Pdx1 expres-
sion. Thus, P300 expression was measured by qRT-PCR 
and Western blot, and the results indicate that P300 
protein is decreased in cells treated with DETA-NO, 
although there is no change in its mRNA (Fig. 3A and 
B). In addition, P300 is also released significantly from 
the Pdx1 promoter after DETA-NO exposure and in the 
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absence of LIF (Fig. 3C). In order to test the relevance 
of P300 in repressing Pdx1, DETA-NO-exposed cells 
were treated with the P300 inhibitor (P300i) and a syn-
ergistic effect of both molecules on Pdx1 expression was 
observed (Fig. 3E). Furthermore, ChIP studies corrob-
orate that JARID-2 and P300 occupy the same region 
on the Pdx1 promoter. Finally, coimmunoprecipitation 
reveals that P300 interacts with PRC2 at the Pdx1 pro-
moter region (Fig. 3D).
Optimized Protocol to Generate 
Insulin-Producing Cells
In view of the relevance of P300 on the regulation of Pdx1 
expression, a modification of a protocol developed previously 
Figure 1. Nitric oxide effects on Pdx1 expression in R1/E mESCs. (A) Relative expression of Pdx1 by real-time polymerase chain 
reaction (PCR). These values are normalized to the expression values of b-actin, used as loading control and analyzed using the DDCt 
algorithm. It represents an average of three independent experiments. Data are presented as mean ± SEM. The y-axis corresponds 
to relative expression level of Pdx1 (fold change). (B) Western blot of PDX1. It shows the results of Western blot of PDX1 in the 
four culture conditions. b-Actin was used as loading control. The blot is representative of three independent experiments. (C) PDX1 
immunofluorescence. Images show cells cultured in the four conditions and subsequently stained with DAPI (blue), PDX1 (red), and 
a-tubulin (green). Scale bars: 25 μM. The images shown are representative of three independent experiments. (D) Flow cytometry of 
PDX1. The green graph shows the +LIF conditions, and the blue graph shows the −LIF conditions. (E) Flow cytometry of PDX1. The 
graph represents the percentage of Pdx1-positive cells in the four culture conditions and negative controls, primary, and secondary anti-
bodies. (A and E) *p < 0.05 statistically significant versus cells cultured in the presence of LIF, **p < 0.05 versus cells cultured in the 
presence and absence of LIF. +LIF: cells cultured in the presence of LIF; +LIFNO: cells cultured in the presence of LIF plus 500 μM 
DETA-NO; −LIF: cells cultured without LIF; −LIFNO: cells cultured without LIF plus 500 μM DETA-NO. In the four conditions, cells 
are cultured for 4 days and with DETA-NO for 19 h.
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Figure 2. Analysis of epigenetic changes of Pdx1 promoter. (A) Pdx1 promoter scheme. This image shows the Pdx1 promoter and 
gene. Horizontal gray rectangles represent CpG islands, and vertical lines are the CpG sites. Vertical gray rectangles represent the 
transcription start (TSS) and the translation start (+1). The arrows represent the pairs of primers designed to amplify the regions of 
interest. (B) Methylation analysis of distal CpG island and proximal CpG island by BSP. It shows the CpG sites studied (distal CpG 
island and proximal CpG island). These sites are represented by circles: white circles, those CpG sites whose percentage of methylation 
is very low or even zero; black circles, those CpG sites whose methylation level is high or complete. Among them, there is a gradient 
of methylation that is shown in the inset of the image. (C) Methylation analysis of distal CpG islands and proximal CpG islands by 
bisulfite pyrosequencing. This graph represents the percentage of methylation of studied CpG sites. Diamonds: R1/E cells cultured in 
the presence of LIF. Squares: R1/E cells cultured in the presence of LIF plus 500 μM DETA-NO. Triangles: R1/E cells cultured in the 
absence of LIF. Full circles: R1/E cells cultured without LIF plus 500 μM DETA-NO. Open circles: INS-1E cells whose methylation 
level was used as control. (D) Analysis of acetylated H3 occupancy at Pdx1 by chromatin immunoprecipitation assay (ChIP). This 
graph represents ChIP analysis for acetylated H3 expressed as relative percent input (relativized to the condition favoring cell pluri-
potency) of three independent experiments. Data are mean ± SEM. (E) Stacked bars for bivalent mark dynamics of H3K27me3 and 
H3K4me3. They represent an average of three independent experiments. +LIF: cells cultured in the presence of LIF; +LIFNO: cells 
cultured in the presence of LIF plus 500 μM DETA-NO; −LIF: cells cultured in the absence of LIF; −LIFNO: cells cultured without 
LIF plus 500 μM DETA-NO. In the four conditions tested, cells are cultured for 4 days and with DETA-NO for 19 h.
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was implemented6. The modification consisted of the addi-
tion of P300i (C646) after treatment with valproic acid and 
before growth in suspension for 3 days (Fig. 4A). Cell mor-
phology and fate were affected after every step of the proto-
col. Thus, exposure to DETA-NO led to substantial cell death, 
and the surviving cells acquired an epithelial morphology. 
Following exposure to valproic acid, groups of cells formed 
colonies with a round and shiny morphology, while others 
remained scattered and dull. Addition of P300i provoked 
considerable cell death, but surviving cells formed cluster- 
like structures. Finally, culture in suspension led to the for-
mation of islet-like clusters (Fig. 4B). Analysis of expres-
sion markers revealed that DETA-NO treatment led to an 
increase in Pdx1, Nkx6.1, Nkx2.2, Ptf1a, and Glut2 mRNA 
(Fig. 4C and D). Interestingly, NO also increased pre-mRNA 
Ins1 levels (Fig. 4C). Valproic acid treatment enhanced the 
expression of definitive endoderm genes, including SRY 
(sex-determining region Y)-box 17 (Sox17), forkhead box A2 
(FoxA2), HNF1 homeobox B (Hnf1b), and NK2 homeobox 
2 (Nkx2.2). At day 10, there was a decrease in Pdx1 expres-
sion, which was recovered by exposure to P300i. Moreover, 
P300i also enhanced Pax4 expre ssion. At the end of the 
differentiation protocol, markers of definitive endoderm 
(Sox17, Foxa2, and Hnf1b) and some markers of pancreatic 
progenitors (Pdx1, Pax4, Nkx6.1, Nkx2.2, Kir6.2, GcK, Ins1, 
and Glut2) were also upregulated (Fig. 4D). Cluster forma-
tion has been reported to improve long-term maintenance of 
human islets in vitro31 and to increase the percentage of insu-
lin-expressing cells in differentiation protocols32. Moreover, 
suspension culture enables uniformity of cellular composi-
tion, and pancreatic aggregates can be implanted without dis-
rupting the maturing cellular architecture33. In our protocol, 
it is interesting to note that these cells were negative for Gcg, 
Amy2, and Sst (Fig. 4C). Immunofluorescence revealed that 
most cells expressed PDX1 and GLUT2, and some of them 
were positive for C-peptide (Fig. 5A).
Figure 3. Studies on polycomb repressive complex (PRC2) in R1/E mESCs. (A) Study of PRC2 and P300 expression by real-time 
PCR. Values are normalized to the expression of b-actin and analyzed using the DDCt algorithm. It represents an average of three 
independent experiments. Data are mean ± SEM. The y-axis corresponds to relative expression level (fold change). (B) Study of PRC2 
and P300 expression by Western Blotting. The image shown is representative of three independent experiments. b-Actin was used as 
a loading control. (C) Analysis of JARID-2 and P300 occupancy at Pdx1 proximal promoter by ChIP. Data are mean ± SEM of three 
independent experiments. The y-axis corresponds to relative percent input from undifferentiated cells. (D) Coimmunoprecipitation 
assay of JARID-2, EZH2, and P300. Three percent of total coimmunoprecipitated protein was loaded as input. Proteins not retained 
to complex agarose beads and Jarid-2 antibody were loaded as control of immunoprecipitation grade (Flow through). An immunopre-
cipitation with IgG antibody was developed as control of nonspecific binding (IgG control). (E) Pdx1 expression analysis by real-time 
PCR. Data are normalized to the expression values of b-actin, used as loading control and analyzed using the DDCt algorithm. Data 
are mean ± SEM of three independent experiments. The y-axis corresponds to relative expression level of Pdx1 (fold change). *p < 0.05 
versus cells cultured in the presence of LIF, **p < 0.05 versus cells cultured in the presence and absence of LIF, ***p < 0.05 versus cells 
cultured in the presence of LIF plus 500 μM DETA-NO. +LIF: cells cultured in the presence of LIF; +LIFNO: cells cultured in the pres-
ence of LIF plus 500 μM DETA-NO; −LIF: cells cultured without LIF; −LIFNO: cells cultured without LIF plus 500 μM DETA-NO. 
In the four conditions cells were cultured for 4 days and with DETA-NO for 19 h.
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A key functional feature of b cells is the ability to 
release insulin in response to secretagogues. Cell clus-
ters generated with the protocol reported here display 
responsiveness to both high glucose and KCl (Fig. 5B). 
A summary of the findings reported here on Pdx1 
regulation and its contribution to the differentiation 
of mESCs into insulin-producing cells is shown in 
Figure  6.
DISCUSSION
Pdx1 is a transcription factor necessary for pancre-
atic development and b-cell maturation and exhibits a 
Figure 4. Differentiation protocol to generate insulin-producing cells from mESCs. (A) Differentiation protocol scheme showing 
the culture conditions. (B) Bright-field images showing colony morphology of D3 mESCs during the differentiation protocol. Scale 
bars: 3,000 μm. (C) Qualitative analysis by RT-PCR for pancreatic markers for each step of differentiation protocol. Visc: embryo 
viscera, Panc: adult pancreas, Islets: mouse islets were used as a control. b-Actin was used as loading control cDNA. The image shown 
is representative of three to five independent experiments. (D) Quantitative analysis by real-time PCR for pancreatic markers. These 
values are normalized to the expression values of b-actin, used as loading control and analyzed using the DDCt algorithm. Data shown 
are mean ± SEM of three independent experiments. The y-axis corresponds to relative expression (fold change). *p < 0.05 statistically 
significant from the previous day of the differentiation protocol shown.
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biphasic pattern of expression during pancreatic devel-
opment34. An appropriate regulation of its expression 
might be instrumental for the generation of insulin-
producing cells from pluripotent stem cells. The pres-
ent study shows that exposure of mESCs to 500 μM 
DETA-NO leads to enhanced and transient expression 
of Pdx1. It has been previously reported that NO induces 
epigenetic changes such as DNA methylation35. In fact, 
methylation of the proximal CpG island of the Pdx1 
promoter is associated with Pdx1 silencing in intrauter-
ine growth retardation (IUGR)12,28. Therefore, we stud-
ied the methylation degree of the Pdx1 promoter by BSP 
Figure 5. Islet-like clusters generated by differentiation protocol. (A) Immunofluorescence of islet-like clusters obtained by 
directed differentiation of D3 mESCs. Left: Immunofluorescence of DAPI (blue), PDX1 (green), and C-peptide (red). Right: 
Immunofluorescence of DAPI (blue), PDX1 (green), and GLUT2 (red). Scale bars: 25 μM. (B) Box and whiskers plot of secreted 
insulin from differentiated islet-like clusters from mESCs. Each black circle is the value for an experiment (n = 6). Insulin secretion 
(ng insulin/mg DNA) at 3 mM glucose ranged from 2.74E−4 to 2.15E−3 (*) and 4.31E−4 to 2.53E−3 at 20 mM glucose. At 25 mM 
KCl, the values ranged from 2.01E−4 to 4.61E−3. * denotes an outlier. The thick horizontal line denotes the median.
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and pyrosequencing. The studies show that the proximal 
CpG island represents less than 20% of overall methyla-
tion, while methylation of the distal island represents 
more than 60%. Methylation levels of both islands are 
slightly increased after NO treatment, despite the sig-
nificantly increased expression of the gene. Thus, it 
is entirely possible that methylation of the Pdx1 pro-
moter might represent a poised state of Pdx1 during 
differentiation of mESCs. On the other hand, methyla-
tion induced by NO treatment in mESCs is similar to 
the pattern observed in the glucose-responsive b-cell 
line (INS-1E). The fact that only conserved sequences 
in the promoter region undergo changes in the degree 
of methylation supports a possible role for this modi-
fication in the epigenetic regulation of Pdx1 gene 
expression. Furthermore, the level of methylation of the 
Figure 6. Overview of Pdx1 regulation by NO and its contribution to the generation of insulin-producing cells from mESCs. (A) Pdx1 
promoter in untreated mESCs and after NO treatment. In untreated mESCs, Pdx1 gene expression is repressed by PRC2, which leads to a 
high occupancy of H3K27me3. NO treatment causes the release of PRC2 and P300 from the Pdx1 promoter, thus allowing gene expres-
sion. Acetylation of H3 remains constant while minor changes in DNA methylation are produced. (B) NO treatment modifies the histone 
marks over the Pdx1 promoter. Exposure to DETA-NO (500 μM) decreases the ratio H3K27me3/H3K4me3. (C) Protocol for mESC 
differentiation into insulin-producing cells. NO treatment releases PRC2 from the Pdx1 promoter and Pdx1 is expressed. Expression of 
endoderm lineage genes (FoxA2, Sox17, and Hnf1b) is observed after valproic acid treatment. Thus, addition of valproic acid (HDAC-I 
inhibitor) allows that chromatin to remain open and helps to differentiate cells into pancreatic lineage cells. In a later stage, inhibition of 
P300 stimulates the expression of pancreatic progenitor markers such as Pdx1 and Pax4. Finally, culture in suspension allows the forma-
tion of islets-like clusters, thus enabling a stable expression of b-cell markers Pdx1, Nkx6.1, Glut2, and Ins1.
Delivered by Ingenta to: Guest User
IP: 193.147.188.5 On: Tue, 31 Jan 2017 08:18:11
Article(s) and/or figure(s) cannot be used for resale. Please use proper citation format when citing this article including the DOI,
1890 SALGUERO-ARANDA ET AL.
proximal promoter in undifferentiated mESCs reported 
here is in accordance with those reported in rodent models 
of IUGR, a condition associated with the onset of type 
2 diabetes12,28. Factors other than methylation might 
control Pdx1 expression in ESCs. It has been reported 
that genes encoding key lineage-specific regulators are 
marked by both H3K4me3 and H3K27me3, creating a 
bivalent state in which genes are poised for future acti-
vation but remain inactive until the repressive mark is 
removed36. ChIP data reported here on H3K27me3 and 
H3K4me3 occupancy agree with studies on bivalency 
during pancreatic differentiation, in which H3K4me3 
and H3K27me3 modifications were mapped in human 
embryonic stem cells (hESCs) at defined stages dur-
ing pancreatic endocrine differentiation3,37. The balance 
in the occupancy of both marks at the Pdx1 promoter 
changes after treatment with NO. Thus, in the pres-
ence of LIF, NO increases H3K4me3 occupancy from 
25% to 40%, and in the absence of LIF increases from 
10% to 40%. These results are in agreement with other 
studies showing progressive decline in the H3K27me3/
H3K4me3 occupancy ratio at the Pdx1 promoter during 
pancreatic development23. In the same light, acetylated 
H3 occupancy at the proximal Pdx1 promoter is not 
altered by NO treatment. The persistence of both AcH3 
and H3K27me3 marks on the silent Pdx1 has been pre-
viously described in hepatoblasts24,38,39. It is possible 
that the presence of acetylated H3 at the Pdx1 promoter 
could also contribute to the poised state of this gene dur-
ing early stages of pancreatic development.
It has been reported that removal of the polycomb 
group (PcG)-mediated repression on stage-specific genes 
is the key regulator during development23. PcG proteins 
have an important role in controlling the expression of 
genes essential for development, differentiation, and 
maintenance of cell fates14,31,40. In the present work, we 
studied the role of components of PRC2 on Pdx1 expres-
sion in mESCs. NO treatment decreases JARID-2 expres-
sion, which is essential for binding of the PRC2 to target 
genes in ESCs18. We report here that JARID-2 is found on 
the Pdx1 promoter in the presence of LIF and is released 
from the promoter after LIF withdrawal and NO treat-
ment. mESCs contain high levels of JARID-2 protein 
that interact with and stabilize PRC2 at target genes17,18. 
We detected JARID-2/EZH2 complexes under conditions 
favoring cell pluripotency, thus suggesting that binding 
of the PRC2 complex on the Pdx1 promoter is involved 
in its repression. This finding is consistent with studies 
showing that JARID-2 and EZH2 are bound at the Pdx1 
promoter in ESCs and that JARID-2 silencing allows 
higher Pdx1 expression and lower EZH2 occupancy17,24. 
It has also been reported that PRC2 regulates transcrip-
tional repression by catalyzing the di- and trimethylation 
of lysine 27 on histone H3 (H3K27me2/3)20,41. In this 
regard, the studies shown here indicate that NO-driven 
release of JARID-2 is linked to changes in the H3K27me3/
H3K4me3 balance at the Pdx1 promoter.
Moreover, it has been shown that P300 is necessary for 
acetylation of liver-specific regulatory elements and full 
liver-specific gene activation and that P300 modulates the 
specification of liver progenitors instead of pancreas pro-
genitors24. Here we show that P300 occupancy represses 
Pdx1 expression in undifferentiated mESCs, and that dur-
ing cell differentiation P300 is released from the Pdx1 
promoter. Likewise, chemical inhibition of P300 leads to 
higher expression of PDX1 in cells cultured with LIF and 
DETA-NO when compared with cells cultured with LIF 
and DETA-NO. Moreover, pull-down experiments with 
JARID-2 and EZH2 show that P300 interacts with PRC2 
complex in undifferentiated conditions. These results 
are in agreement with those from previous studies that 
showed that P300 can act as a repressor independently of 
its acetyltransferase activity25,26,42,43. Possible posttransla-
tional modifications such as a SUMO-dependent repres-
sion25 or recruitment of other repressive components such 
as HDAC6 or HDAC126 remain to be studied.
On the basis of the knowledge that P300 is a repres-
sor of the Pdx1 gene and the mechanisms controlling the 
expression of Pdx1 in mESCs, a differentiation protocol was 
designed to generate insulin-producing cells. Previously, we 
reported the generation of definitive endoderm cells with a 
protocol consisting of sequential exposure to DETA-NO, 
serum withdrawal, and treatment with valproic acid6. The 
novel small molecule-based protocol presented here con-
sists of five steps in which cells are differentiated toward 
functional insulin-producing cells in a full in vitro system. 
The expression of Pdx1 by removal of P300 repression is 
instrumental for the development of b-cell surrogates, and 
the combined use of small molecules such NO and valp-
roic acid leads to sequential activation of signals relevant 
for induction of pancreatic lineage cells. The generation of 
cell aggregates with pancreatic progenitor cells at 11 days 
expressing Pdx1 and Pax4 prepared the cells for a consis-
tent maturation step. At the end of the protocol (14 days), 
cells expressing b-cell markers such as Pdx1, Nkx6.1, GcK, 
Kir6.2, Glut2, and Ins1 were capable of responding to secre-
tagogues such as high glucose and KCl.
b-Catenin, activin/nodal, and bone morphogenetic pro-
tein (BMP) signaling pathways are known to have an impor-
tant role during endoderm generation. Thus, activin A is used 
to activate nodal signaling, and Wnt activators or a BMP 
antagonist such as noggin is commonly used for definitive 
endoderm induction from human pluripotent stem cells44–46. 
Another key step is generation of functional hormone- 
secreting cells. A considerable number of molecules have 
been proven to be “maturation fac tors” such insulin-like 
growth factor 1 (IGF-1), exendin-4, hepatocyte growth factor 
(HGF), B27 supplement, betacellulin, or nicotinamide3,47,48. 
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Relevant progress in the field has been reported by Rezania 
et al.48. They have generated in vitro functional b-like cells, 
which permanently reverse hyperglycemia when trans-
planted into diabetic mice. Alternatively, Pagliuca et al. have 
reported a strategy for large-scale production of functional 
human b cells from human pluripotent stem cells generating 
glucose-responsive and monohormonal insulin-producing 
cells8. The increasing number of protocols to generate b-cell 
surrogates from ESCs underscores the collective effort made 
over the past 10 years to generate efficient and reproduc-
ible methods to obtain fully responsive b cells in vitro. The 
findings reported here indicate that promoting the expres-
sion of Pdx1 by removal of PRC2 and P300 repression is 
instrumental for the development of b-cell surrogates. The 
combined use of small molecules such as DETA-NO, val-
proic acid, and P300 inhibitor leads to sequential activation 
of signals important for pancreatic lineage specification. 
Subsequent formation of cell aggregates enables the gen-
eration of glucose-responsive monohormonal insulin-pro-
ducing cells. This protocol is a promising tool for efficient 
generation of b cells from pluripotent stem cells, but further 
testing is needed to determine whether these findings are 
also applicable for human stem cells.
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